Greece – Mu.Ta.Lig – COST ACTION CA15135
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Universal Design: A Step toward Successful Aging – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Amazon.com: Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books
Amazon.com: Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books
Olive Bioactives: applications and prospects | LE STUDIUM
University of Athens | Tascmar
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Loop | Ioannis Trougakos
Home
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Third Dose of the BNT162b2 Vaccine Results in Very High Levels of Neutralizing Antibodies Against SARS‐CoV‐2; Results of a Prospective Study in 150 Health Professionals in Greece - Terpos - - American
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays | Scientific Reports
Ioannis Trougakos * - AD Scientific Index 2022
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text
Prof. Ioannis P. TROUGAKOS – Mu.Ta.Lig – COST ACTION CA15135
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
Cardiotoxicity due to Proteasome Dysfunction | Micro CT
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
